Tag: Prescription Drugs
Major Insurers Offer $55 Million to Lower Generic Drug Costs
Nonprofit Civica Rx reached deal with Blue Cross Blue Shield and 18 of its member organizations
Dasatinib Tops Imatinib for Ph+ Acute Lymphoblastic Leukemia
Four-year cumulative risk of any relapse lower for dasatinib in the context of intensive chemotherapy
CDC: Benzodiazepines Prescribed at 27 Office Visits Per 100 Adults
Overlapping opioid Rx involved in about one-third of visits at which benzodiazepines were prescribed
High-Dose Erythropoietin No Benefit for Extreme Preemies
No reduction found in risk for severe neurodevelopmental impairment or death at 2 years of age
FDA: Weight Control Drug Lorcaserin May Raise Cancer Risk
Health care providers should balance the benefits of taking lorcaserin against the potential risks
2011 to 2017 Saw Increase in Spending on DMTs for MS
Increase in annual expenditures on MS DMTs mainly driven by increases in per-prescription costs
Intensive Systolic BP Control May Not Benefit All Older Adults
No real benefit seen for adults ≥80 years with lower cognitive function
Antipsychotic Use Safer Than No Use in Schizophrenia
No increase seen in severe morbidity, hospitalization when compared with periods of nonexposure
Gout Incidence Down With SGLT2 Inhibitors in Type 2 Diabetes
Gout incidence rate significantly reduced with SGLT2 inhibitor versus GLP-1 receptor agonist
California May Start Producing Its Own Medicines
Proposal also includes a single market for drug pricing in the state
